Previous Article | Next Article ![]()
Journal of Virology, April 2000, p. 3046-3057, Vol. 74, No. 7
Departments of
Microbiology1 and
Medicine,3 College of Physicians and
Surgeons, Columbia University, New York, New York 10032, and
Department of Biochemistry, Biomedical Center, Uppsala,
Sweden2
Received 16 September 1999/Accepted 5 December 1999
Retroviral Gag polyproteins drive virion assembly by polymerizing
to form a spherical shell that lines the inner membrane of nascent
virions. Deletion of the nucleocapsid (NC) domain of the Gag
polyprotein disrupts assembly, presumably because NC is required for
polymerization. Human immunodeficiency virus type 1 NC possesses two
zinc finger motifs that are required for specific recognition and
packaging of viral genomic RNA. Though essential, zinc fingers and
genomic RNA are not required for virion assembly. NC promiscuously
associates with cellular RNAs, many of which are incorporated into
virions. It has been hypothesized that Gag polymerization and virion
assembly are promoted by nonspecific interaction of NC with RNA.
Consistent with this model, we found an inverse relationship between
the number of NC basic residues replaced with alanine and NC's
nonspecific RNA-binding activity, Gag's ability to polymerize in vitro
and in vivo, and Gag's capacity to assemble virions. In contrast,
mutation of NC's zinc fingers had only minor effects on these properties.
Retroviral nucleocapsid proteins
(NC) are expressed as part of a Gag polyprotein that is cleaved by the
virally encoded protease during virion maturation (reviewed in
references 20 and 28). For human
immunodeficiency virus type 1 (HIV-1), the mature Gag proteins include
matrix (MA, p17), capsid (CA, p24), nucleocapsid (NC, p7), and p6. With
the exception of those of spumaviruses, all retroviral NCs contain
either one or two Cys-His boxes
(Cys-X2-Cys-X4-His-X4-Cys), reminiscent of zinc finger motifs found in many DNA binding proteins. In addition, and without exception, all retroviral NCs contain a large
number of basic residues distributed throughout the protein.
NC serves multiple functions in the retroviral life cycle, many of
which stem from its ability to bind nucleic acid. Incorporation of
viral genomic RNA into virions results from a specific
interaction between NC's Cys-His boxes and cis-acting
packaging sequences ( The nonspecific nucleic acid-binding activity of NC has been shown to
be mediated by basic residues distributed throughout the protein
(21, 29, 32, 42, 45) and is consistent with the observations
that NC coats the entire viral genomic RNA in mature virions
and that significant quantities of cellular RNAs, such as 7SL RNA, 5S,
18S, and 28S rRNA, and tRNA, are incorporated into retroviral virions
(for a review see reference 3). Given that NC is the
major and most abundant viral RNA-binding protein, incorporation of
these RNAs into virions presumably occurs through nonspecific RNA
binding mediated by NC.
In addition to its role in RNA packaging, the NC domain is the major
domain promoting interactions among Gag polyproteins, and deletion of
NC abrogates virion production. Cys-His boxes play no role in these
processes since disruption of zinc fingers by mutation or by compounds
that oxidize cysteine thiolates has minimal effect on virion production
(for a review see reference 3). In addition,
In contrast to what is found for zinc fingers, data suggest that HIV-1
basic residues mediate Gag-Gag interaction (2, 5) and are
required for virion assembly (15). However, evidence for
involvement of basic residues in Gag-Gag interaction is indirect, and
their role in virion assembly remains unclear in that some have
reported a minimal effect of basic residue mutations on assembly (39, 41).
If NC basic residues do play a role in virion assembly, it would
suggest that the nonspecific RNA-binding activity of these residues
might drive assembly. In support of this model, assembly defects
associated with NC deletion mutants can be partially reversed if
stretches of basic residues are fused to the Gag polyprotein (5) or if NC is replaced with a heterologous RNA-binding
protein (53). Also, in vitro assembly of virion cores from
recombinant protein depends on the presence of nonspecific nucleic acid
(8, 23, 25).
To test the hypothesis that the nonspecific nucleic acid-binding
activity of HIV-1 NC is necessary for Gag-Gag interaction and virion
assembly, we studied a panel of HIV-1 NC mutants in which from 2 to 10 basic residues were replaced with alanine. We show that mutations that
impair NC's nonspecific RNA-binding activity, negatively and
proportionally, affect Gag-Gag interaction and virion assembly.
Mutations in the zinc fingers do not affect NC's nonspecific
RNA-binding activity and have minor effects on Gag-Gag interaction and
virion assembly. These results support the hypothesis that NC's
nonspecific RNA-binding activity is required for Gag-Gag interaction
and provides a driving force for virion assembly.
Plasmid DNA constructs.
HIV-1 proviral DNAs containing
mutations in NC basic residues (41) were obtained from Anna
Aldovini. Fragments encompassing these mutations, as well as the
corresponding region from the wild type, were transferred from the HXB2
provirus into NL4-3 proviral DNA as described below. An
SphI/EcoRI fragment from pNL4-3 (nucleotides 1443 to 5743 [38]) was inserted into the corresponding sites of pUC19 (pUC19NL4-3). An SphI/EcoRV
fragment (nucleotides 1443 to 2977) encompassing the NC coding sequence
was then transferred from HXB2 into pUC19NL4-3. The entire
SphI/EcoRI fragment was then cloned back into
pNL4-3. Proviral DNAs containing mutations in the Cys-His boxes of
HIV-1 NC (18) were obtained from Heinrich Göttlinger.
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Basic Residues in Human Immunodeficiency Virus Type 1 Nucleocapsid Promote Virion Assembly via Interaction with
RNA
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
) in viral genomic RNA. However, in
addition to its sequence-specific nucleic acid-binding activity, NC is
also able to interact nonspecifically with nucleic acid (for reviews
see references 3 and 14). NC's
specific and nonspecific binding activities can act separately or
synergistically on the same nucleic acid molecule, for example, in the
selection of
-RNA, as recently shown by the solution structure of
HIV-1 NC bound to the 14-nucleotide SL3 stem-loop from the HIV-1 RNA
packaging signal (16).

virions assemble efficiently (1, 12, 33),
indicating that viral genomic RNA incorporation is not
necessary for virion assembly.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Cell lines. The human lymphocyte line Jurkat (52) was maintained in RPMI 1640 supplemented with 10% fetal bovine serum. Human 293T and HeLa fibroblasts were maintained in Dulbecco modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum.
Replication assay. Viral infections were initiated in 106 Jurkat cells by DEAE-dextran (250 µg/ml; Pharmacia Biotech Inc., Piscataway, N.J.) using 2 µg of proviral DNA in 1 ml of serum-free RPMI 1640 for 20 min at room temperature. Cells were then washed in serum-free medium and resuspended in 3 ml of conditioned medium. Every 2 days supernatant was harvested and frozen and cells were passaged. At the conclusion of the experiment the stored samples were analyzed for reverse transcriptase (RT) activity as described below.
Exogenous RT assay.
Ten microliters of cell culture
supernatant was added to 50 µl of RT cocktail (60 mM Tris-HCl [pH
8.0], 180 mM KCl, 6 mM MgCl2, 6 mM dithiothreitol, 0.6 mM
EGTA, 0.12% Triton X-100, 6 µg of oligo[dT]/ml, 12 µg of
poly[rA]/ml, 0.05 mM [
-32P]dTTP [800 Ci/mmol]) for
1 h at 37°C. Two microliters was spotted onto DE-81 paper and
washed three times with 2× SSC (1× SSC is 0.15 M NaCl plus 0.015 M
sodium citrate) (43). A phosphorimager (Molecular Dynamics,
Sunnyvale, Calif.) was used to quantitate the radioactivity incorporated.
Metabolic labeling and immunoprecipitation. HeLa cells in 35-mm-diameter plates were transfected with proviral DNAs using calcium phosphate as previously described (11). Forty-eight hours posttransfection, cells were incubated for 1 h at 37°C with 2 ml of DMEM lacking methionine and cysteine prior to a 45-min pulse with 100 µCi of [35S]Met-[35S]Cys (Translabel; ICN). Cells were washed with phosphate-buffered saline (PBS), incubated with complete DMEM, and lysed 0, 1, 3, and 6 h later in radioimmunoprecipitation assay (RIPA) buffer (150 mM NaCl, 1% NP-40, 0.5% deoxycholate, 0.1% sodium dodecyl sulfate [SDS], 50 mM Tris-Cl, pH 8.0). Virions were purified from the supernatant by ultracentrifugation for 2 h at 80,000 × g through a cushion of 25% (wt/vol) sucrose; the pellet was resuspended in RIPA buffer. Cell lysate- and virion-associated fractions were incubated with 100 µl of protein A-Sepharose beads (Sigma; 10% slurry in RIPA buffer) for 1 h at 4°C. Supernatant was removed from the beads and incubated with 25 µg of total immunoglobulin from an HIV-1-infected individual (sera were obtained through the AIDS Research and Reference Reagent Program; catalog no. 3957) for 2 h at 4°C. Protein A-Sepharose beads (100 µl) were then added for 1 h at 4°C. Beads were washed three times, and proteins bound to the beads were analyzed by SDS-polyacrylamide gel electrophoresis (PAGE) and phosphorimager quantification.
Virion purification. 293T cells or HeLa cells were transfected (see above) with Gag expression plasmids or with complete proviral DNAs. At 72 h posttransfection, culture supernatant was filtered with a syringe (0.45-µm pore size), layered on 2 ml of 25% (wt/vol) sucrose, and accelerated at 80,000 × g for 2 h. Pelleted virions were resuspended in the appropriate buffer and analyzed.
For linear sucrose density analysis, virions pelleted as described above were resuspended overnight in 200 µl of RPMI 1640 on ice. Virions were then loaded on a linear sucrose gradient (20 to 60% [wt/vol]) and accelerated at 80,000 × g for 24 h. Fractions were harvested, and exogenous RT activity and solution density were measured.Analysis of HIV-1 virion morphology by electron microscopy. 293T cells were transfected with HIV-1 proviral DNAs. Cells were fixed 72 h posttransfection with freshly made 2.5% glutaraldehyde in phosphate buffer (pH 7.0). Cells were postfixed in 1% osmium tetroxide and then embedded in Epon. Poststaining was done with 1% uranyl acetate. Sections were cut approximately 60 nm thick to accommodate the volume of the core structure parallel to the section plane. Specimens were analyzed with a Zeiss CEM 902 electron microscope, equipped with a spectrometer to enhance image contrast, at an accelerating voltage of 80 kV. A liquid nitrogen cooling trap on the specimen holder was used throughout. For each mutant, a series of electron micrographs (200 to 500 virions) was used for the statistical evaluation of the different morphologies present in the sample. The only exception was M1-2/BR for which only 20 particles were identified.
Protein expression and in vitro protein-binding experiments. Proteins were expressed in Escherichia coli strain BL21(DE3)LysS (Novagen), as previously described (34). Cells were lysed in a solution consisting of 20 mM HEPES (pH 6.8), 150 mM potassium acetate, 2 mM magnesium acetate, 2 mM dithiothreitol, 0.1% Casamino Acids, 1% Tween 20, and 1 mM phenylmethylsulfonyl fluoride. In vitro GST pull-downs were performed as previously described (34) with the above-mentioned buffer. The quantity of bound protein was determined by densitometric analysis of the signals obtained after Western blotting.
Antibodies and Western blot analysis. Murine monoclonal anti-HA antibody was purchased from Berkeley Antibody Company (Berkeley, Calif.). Rabbit polyclonal anti-cyclophilin A antibody was purchased from Affinity BioReagents (Golden, Colo.). Western blot analysis was performed as previously described (34).
In vitro RNA-binding assay. GST-NC fusion proteins were immobilized onto glutathione-agarose beads (Sigma) and washed in binding buffer (50 mM Tris-HCl [pH 8.0], 50 mM NaCl, 10 µM NaCl2). In vitro-transcribed 32P-labeled RNA (4 × 104 cpm; specific activity, 5 × 105 to 6 × 105 cpm/µg) was added to immobilized GST-NC proteins for 30 min at 4°C in a total volume of 200 µl of binding buffer. After the washing, the radioactivity present in the samples was determined by direct counting using a beta counter (Beckman; L56000SC). Proteins bound to the beads were solubilized in SDS gel loading buffer and analyzed by Coomassie staining.
In vitro RNA transcription.
RNA was made with a kit
(mMESSAGE-mMACHINE; Ambion) according to the manufacturer's
directions. Two DNA templates were used. For synthesis of
"nonspecific RNA" pBSKSII
(Stratagene) was linearized with XhoI and transcribed using T7 polymerase. The product
was a linear 110-nucleotide RNA, encompassing sequences from the
plasmid polylinker. To produce an RNA that encompasses the HIV-1
packaging sequence (nucleotides 455 to 788),
pGL-leader-luciferase (11) was linearized with
XhoI and transcribed with T7 polymerase.
Dot blot analysis. Virions produced by calcium phosphate transfection of 293T cells were purified by ultracentrifugation through 25% (wt/vol) sucrose as described above and resuspended in PBS. Virions were normalized by exogenous RT activity and transferred to a nylon membrane using a dot blot apparatus (Bio-Rad). The membrane was incubated overnight at 42°C in 10% polyethylene glycol-1.5× SSPE (1× SSPE is 0.18 M NaCl, 10 mM NaH2PO4, and 1 mM EDTA [pH 7.7])-7% SDS-100 µg of salmon sperm DNA/ml, with a 32P-end-labeled DNA oligonucleotide (5'-CTGACGCTCTCGCACCC-3'; antisense nucleotides 808 to 792 from pNL4-3) that hybridizes with HIV-1 genomic RNA (36). The membrane was washed in 0.1% SDS-0.2× SSC and exposed for phosphorimager analysis.
In vivo complementation assay. 293T fibroblasts were cotransfected with DNAs encoding a myristylation-deficient HA-Gag polyprotein and a complete NL4-3 provirus. The NL4-3 construct bears the protease-inactivating mutation D25R (49) and is wild type with respect to its gag sequence. NC mutations were expressed in the context of HA-Gag. Virions in the supernatant were purified by ultracentrifugation 48 h posttransfection, as described above. Pellets were resuspended in PBS, normalized by exogenous RT activity, and analyzed by Western blotting.
Analysis of intracellular detergent-resistant complexes. HeLa cells were transfected by calcium phosphate with proviral DNAs in 35-mm-diameter plates. Forty-eight hours posttransfection, cells were incubated for 1 h at 37°C with 2 ml of DMEM lacking methionine and cysteine. Cells were pulsed for 2 h with 100 µCi of [35S]Met-[35S]Cys (Translabel; ICN). Cells were washed once with PBS and lysed in PBS containing 1% Triton X-100 and 1 mM phenylmethylsulfonyl fluoride for 4 h on ice. The soluble fraction was harvested from the plate and spun on a tabletop centrifuge for 5 min at 3,000 rpm, and the supernatant was loaded on a linear sucrose gradient (20 to 60% [wt/vol]) for 24 h at 80,000 × g. Thirteen fractions were harvested from the top of the gradient. The density of each fraction was measured. Proteins in each fraction were immunoprecipitated with serum from an HIV-1-infected individual as described above. Samples were subjected to SDS-PAGE, and gels were dried and analyzed by phosphorimager analysis.
| |
RESULTS |
|---|
|
|
|---|
Mutations in HIV-1 NC basic residues impair viral replication.
To determine the role of HIV-1 NC basic residues in virion assembly, NC
mutants were selected for a study in which 1, 2, 4, 6, or 10 basic
amino acids were replaced with alanine (Fig.
1). The engineering of these mutants has
been described previously (41).
|
|
|
Mutations in HIV-1 NC basic residues impair virion assembly.
To identify the step in the retroviral replication cycle that was
disrupted by the HIV-1 NC mutations, we began by examining virion
assembly. Proviral DNAs were transfected into HeLa cells. Viral
proteins were metabolically labeled with [35S]methionine
and [35S]cysteine for 45 min and chased with cold medium
for 0, 1, 3, and 6 h (Fig. 3). Cells
were lysed, and viral proteins were immunoprecipitated using serum from
an HIV-1-infected individual. Cell-free, virion-associated proteins
were purified by ultracentrifugation through 25% sucrose prior to
immunoprecipitation. Samples were processed by SDS-PAGE, and signal
intensity was quantitated by phosphorimager analysis. For each mutant
the amount of particulate protein released was normalized to the
wild-type amount using the amount of cell-associated viral protein
labeled at time zero.
|
Effect of HIV-1 NC basic residue mutations on virion
morphology.
The effect of basic residue mutations on virion
structure was examined by electron microscopy. Cells transfected with
wild-type provirus produced mature, budding particles with typical
cone-shaped, high-density core structures (Fig. 4A and
B). Particles produced by mutant R3 had a
morphology similar to that of the wild type (Fig. 4C and D), although
56% of the virions had an immature morphology with polyproteins
tightly packed inside the envelope. Particles seen with mutant 10-11 were largely immature (79%) with a rim of high-density material inside
the envelope (Fig. 4E and F).
|
Virion density is not altered in HIV-1 NC mutants.
Since
electron microscopy revealed alterations in the structure of the mutant
virions, experiments were performed to determine if virion density was
altered. Virions produced by transfection of 293T cells were loaded
onto linear sucrose density gradients (20 to 60%) and accelerated at
80,000 × g for 24 h. Twelve fractions were
collected, and solution density and exogenous RT activity were
determined for each (Fig. 5). The
densities of all mutant virions were determined to be 1.16 to 1.18 g/ml, within the normal limit for retroviral virions. Similar results
were obtained with virions produced from HeLa cells and when virions
were quantitated by p24 (data not shown).
|
Mutations in HIV-1 NC basic residues impair virion incorporation of
viral genomic RNA.
Two different assays were performed to
test the ability of the NC mutants to interact with nucleic acid. In
the first assay we determined the quantity of viral genomic RNA
packaged into mutant virions as a measure of NC's ability to interact
with RNA in vivo (Fig. 6A and B and Table
1). Virions produced by transfection of proviral DNAs into 293T cells
were purified by ultracentrifugation through 25% sucrose. The
quantities of particles produced by the wild type and by the different
mutants were normalized to each other by measuring exogenous RT
activity. Virions were blotted on a nylon membrane and probed with a
32P-labeled oligonucleotide specific for viral
genomic RNA. A strong signal was obtained with wild-type
virions (Fig. 6A). With twofold dilutions of the wild-type sample a
linear decrease in signal was observed (Fig. 6A). The signal obtained
after hybridization was not due to RNA from lysed cells or from
transfected plasmid DNA since supernatant pelleted from cells
transfected with a provirus encoding an assembly-defective virus gave
no signal (Fig. 6B, mock lane). When NC mutant virions were tested, a
proportional decrease in viral genomic RNA incorporation as
more basic residues were replaced with alanine was observed. Compared
to that for the wild type, the reduction in signal ranged from 45% for
mutant R3 to 2% for mutant M1-2/BR (Fig. 6B).
|
Mutations in HIV-1 NC basic residues impair NC's nonspecific RNA-binding activity. An in vitro assay was established to determine if the NC mutations disrupted nonspecific binding to RNA. Each NC mutant was expressed as a GST fusion protein and immobilized on glutathione-agarose beads. Beads with bound protein were washed and resuspended in a solution containing 32P-labeled RNA that was transcribed in vitro using pBluescript as the template. After extensive washing, radioactivity that remained associated with the beads was counted as an indication of the quantity of RNA bound to NC.
A strong signal was obtained with wild-type GST-NC (Fig. 6C). The signal decreased in a linear fashion when decreasing amounts of GST-NC were bound to the beads. Compared to that of wild-type GST-NC, a decrease in RNA-binding ability was observed with the NC mutants as an increasing number of basic residues were replaced with alanine (Fig. 6D and Table 1). The disruptive effect of the NC mutations was confirmed in Northwestern and Southwestern assays using either 32P-labeled RNA or DNA probes, respectively (data not shown). The disruption of RNA binding by the NC mutants was not explained by differences in the loading of mutant proteins, as shown by Coomassie staining of SDS-PAGE gels (Fig. 6D, bottom).HIV-1 NC basic residues are required for Gag-Gag interaction.
The effect of the HIV-1 NC mutants on the Gag-Gag interaction was
tested using two different assays. First, GST-NC mutant proteins
were assayed for the ability to interact in vitro with full-length
HA-tagged Gag (Fig. 7A). We have
previously characterized the interaction between Gag and NC
in vitro and have shown that the interaction is dependent on RNA
(7). GST-NC fusion proteins were immobilized onto
glutathione-agarose beads and incubated with a lysate of bacteria
expressing full-length HA-Gag. Samples were washed, and, after
SDS-PAGE, bound proteins were detected by Western blotting using an
anti-HA antibody (Fig. 7A, top) and by Coomassie staining (Fig. 7A,
bottom). The greater the number of basic residues that were mutated to
alanine, the poorer was the ability of NC to bind HA-Gag. The R3
mutation, with only a single residue mutated, had no appreciable effect
on the Gag-Gag interaction (data not shown and Table 1). The lysate of
bacteria expressing HA-Gag shows four major bands resulting from
C-terminal truncation. Previous analysis demonstrated that only the
three lower-mobility bands retain the complete NC domain
(35). Interestingly, these three bands and not the fourth,
which lacks NC, bind to GST-NC.
|
NC-p6) could not be detected under the conditions used here. As an
increasing number of NC basic residues were replaced with alanine, the
HA-Gags showed a progressive defect in their abilities to be rescued
into virions by wild-type Gag. In contrast, incorporation of
cyclophilin A, a cellular protein that binds the CA domain (6,
34), was unaffected by the presence of the NC mutations (Fig. 7C,
middle). Differences in the efficiency of mutant HA-Gag incorporation
into virions could not be explained by instability of the mutant
proteins as judged by Western blotting (Fig. 7C, bottom) or by
pulse-chase analysis (data not shown).
Intracellular, detergent-resistant Gag complexes are disrupted by
basic-residue mutations.
Detergent-resistant, intracellular
complexes of the HIV-1 Gag polyprotein have been observed in
virus-producing cells (31). Deletion of NC abolishes their
formation (30), suggesting that these complexes are
dependent on the Gag-Gag interaction. To determine if mutation of basic
residues disrupts the formation of these complexes, HeLa cells were
transfected with proviral DNAs, those of either the wild type or mutant
M1-2/BR. Cells were pulsed with [35S]methionine and
[35S]cysteine for 2 h and incubated for 4 h in
the presence of 1% Triton X-100. The soluble fraction was loaded onto
a linear sucrose gradient (20 to 60%) and accelerated at
80,000 × g for 24 h. Thirteen fractions were
collected from the top of the gradient. Density was measured for each
fraction prior to immunoprecipitation of viral proteins using sera from
an HIV-1-infected individual (Fig. 8A).
For both wild-type and mutant viruses, Env protein localized at the top
of the gradient. For the wild-type virus, unprocessed Gag polyprotein
was found in low-density fractions but a significant portion also
formed complexes of higher density that extended the length of the
gradient. With the M1-2/BR mutant the Gag polyprotein complexes were
found only in the lower-density fractions, indicating that, by
disrupting the Gag-Gag interaction, this mutant impaired the formation
of intracellular complexes (Fig. 8B).
|
HIV-1 NC zinc fingers are dispensable for nonspecific RNA binding activity and Gag-Gag interaction. NC zinc fingers are required for packaging viral genomic RNA and for virion infectivity, but, unlike the NC basic residues, they are dispensable for virion assembly (for a review see reference 3). We therefore examined the effect of zinc finger mutants on our in vitro assays for nonspecific RNA-binding activity and for Gag-Gag interaction. Previously characterized zinc finger mutants (18) F16A, C18S, F16A/W37A, and C28/C49S were selected for comparison with the basic-residue mutants. Each of these mutations has been shown to have drastic effects on the packaging of viral genomic RNA into virions, with relatively modest effects on virion assembly (18) (data not shown).
GST-NC fusion proteins, either wild type or bearing one of the zinc finger mutations, were analyzed for the ability to bind to nonspecific RNA in vitro (Fig. 9A). Disruption of one (F16A, C18S) or two (F16/W37A, C28/C49S) zinc fingers had only a minor effect on the ability of these mutants to associate with RNA. These results contrast with the dramatic effect of the basic-residue mutations in this same assay (Fig. 6D).
|
| |
DISCUSSION |
|---|
|
|
|---|
By analyzing the phenotype of a panel of HIV-1 NC basic-residue mutants we have obtained data in support of a model in which HIV-1 Gag polymerization and virion assembly are promoted by interaction of the NC domain with RNA. We demonstrated that the number of NC basic residues that are mutated correlates with the magnitude of the defects in virion assembly. The assembly defect was not due to decreased translation efficiency or decreased protein half-life. Some have reported the viral protease dependence of assembly defects associated with Gag mutants (26). We examined the effect of mutational inactivation of the viral protease on our mutants and saw no correction of the impairment in virion release (data not shown).
Defects in virion assembly due to NC basic-residue mutations have been reported by some (15) but not by others (41). Our results are contrary to those described by the latter group. Differences in the techniques used to study virion assembly may account for this discrepancy. Poon et al. (41) used Western blot analysis, a method that assays steady-state protein accumulation. We used pulse-chase analysis, which provides a detailed kinetic analysis of virion assembly. By using this technique, we clearly showed a defect in the assembly of NC basic-residue mutants. This defect was not cell line dependent, since the same results were observed using HeLa, COS, and 293T cells (data not shown).
In addition to being associated with the assembly defect, the NC mutations were associated with decreased processing of the Gag polyprotein by the viral protease. Consistent with the biochemical evidence for a protease processing defect, visualization of virus-producing cells by electron microscopy showed that a higher proportion of mutant virions exhibit immature morphology. Similar effects of NC basic-residue mutations on virion morphology have been reported (4, 39). The viral protease defect is not explained by differential incorporation of Gag versus Gag-Pol into mutant virions since the Gag/Gag-Pol ratio is normal (data not shown). Although it is possible that the protease processing defect results from decreased numbers of Gag and Gag-Pol molecules per virion, we believe that it results from decreased RNA-binding activity by the NC mutants. HIV-1 viral protease processing has been shown to be RNA dependent in vitro (47, 48), and in our mutants, the protease processivity defect is proportional to the number of basic residues mutated. Although the RNA dependence of viral protease processing has only been demonstrated with a p15 substrate (NC-p6) in vitro, this requirement may be applicable to other protease cleavage sites in vivo. RNA dependence may be most obvious at sites with low affinity for the viral protease, thus explaining why we observe the accumulation of the CA/SP1 intermediate in our mutants.
Our data show that NC basic residues mediate nonspecific RNA recognition in vitro and contribute to viral genomic RNA incorporation into virions. These findings provide a link between previous studies on the importance of NC basic residues for RNA binding in vitro (17, 29, 45) and in vivo (15). The defect in nucleic acid binding was proportional to the number of basic residues of NC replaced, indicating that the number of basic charges determines NC's ability to bind nonspecifically to RNA. Our results are in agreement with nuclear magnetic resonance data showing that NC basic residues associate nonspecifically with phosphodiester groups on RNA (16). However, our data do not exclude the possibility that specific basic residues make larger contributions than others to NC's nonspecific RNA-binding activity or to virion assembly.
Many groups have demonstrated that NC is required for virion assembly (10, 15, 24, 27). Evidence that NC's role in assembly is to promote Gag-Gag interaction has been provided by trans-complementation assembly assays (2), two-hybrid experiments (19, 51), ligand affinity blotting (10), GST pull-down assays with recombinant protein in vitro (7), and cysteine cross-linking (37). Our data show that basic residues distributed throughout NC contribute to virion assembly by promoting interactions among Gag molecules. This was demonstrated by showing a correlation between the number of NC basic residues replaced with alanine and defects in the Gag-Gag interaction in vitro and in vivo. In addition, mutations in the basic residues of NC disrupt the formation of intracellular, detergent-resistant Gag complexes. These complexes are formed shortly after protein synthesis and have high density, indicating that they are multimeric structures of the Gag polyprotein. Though these high-density complexes have not been proven to be assembly intermediates, we believe that by disrupting Gag polymerization, NC basic-residue mutations might directly prevent the formation of these complexes and the subsequent nucleation of nascent virions at the cell surface. Alternatively, by impairing the Gag-Gag interaction the NC mutations might interfere with Gag's ability to bind the plasma membrane, as suggested by others (40, 44), and thus block assembly.
Virions produced by NC deletion mutants have decreased density (2, 15). It has been proposed that the decreased density is due to the formation of virions processing fewer Gag molecules per virion, secondary to the weakened Gag-Gag interaction (50). In contrast to findings concerning the deletion mutants evaluated in those papers, we found here that virions produced by NC basic-residue mutants have a normal density. Since we have shown directly that the basic-residue mutants weaken the Gag-Gag interaction it appears that virion density is determined by some other property of Gag. Alternatively, the basic residues that remain in our most drastic mutant (M1-2/BR) may be sufficient for the minimal Gag-Gag interaction required to assemble virions of normal density.
Correlation between the effects of NC mutants on RNA binding and the effects on Gag-Gag interaction suggests that RNA is required for Gag polymerization. In fact, the NC assembly function can be performed instead by a heterologous RNA-binding protein (53). RNA promotes the formation of virion core structures from recombinant protein in vitro. RNase disrupts these structures (9) and disrupts the interaction between Gags in a GST pull-down as well (7).
RNA might promote Gag multimerization via any of a number of mechanisms. By binding to the basic residues in NC, RNA might neutralize charge repulsion between Gag polyprotein monomers. This would then permit protein-protein contacts involving NC or perhaps the CA-dimer interface (7, 22). Though this model is supported by the observation that virion cores assemble in vitro in the absence of RNA (albeit inefficiently) as long as the salt concentration is very high, no protein-protein contacts in the structure of HIV-1 NC bound to the HIV-1 SL3 RNA stem-loop were observed (16). This indicates that if direct protein-protein interactions do occur among Gag molecules, the contacts do not involve NC residues. We favor the hypothesis that RNA acts as a scaffold for Gag multimerization. The binding of Gag (via NC) to RNA would drive Gag accumulation and create a favorable environment for the formation of protein-protein contacts among CA and possibly MA domains, thus driving virion assembly.
| |
ACKNOWLEDGMENTS |
|---|
We thank Anna Aldovini, Heinrich Göttlinger, and Flossie Wong-Staal for generously providing plasmid DNAs. We thank Cagan Gurer for critical reading of the manuscript.
This work was supported by grant AI 41857 (J.L.) and by shared core facilities of the Columbia-Rockefeller Center for AIDS Research (P30 AI42848), both from the National Institutes of Health.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Departments of Microbiology and Medicine, College of Physicians and Surgeons, Columbia University, 701 W. 168th St., New York, NY 10032. Phone: (212) 305-8706. Fax: (212) 305-0333. E-mail: Luban{at}cuccfa.ccc.columbia.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Aldovini, A., and R. Young.
1990.
Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus.
J. Virol.
64:1920-1926 |
| 2. |
Bennett, R. P.,
T. D. Nelle, and J. W. Wills.
1993.
Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus Gag proteins.
J. Virol.
67:6487-6498 |
| 3. | Berkowitz, R., J. Fisher, and S. P. Goff. 1996. RNA packaging. Curr. Top. Microbiol. Immunol. 214:177-218[Medline]. |
| 4. | Berthoux, L., C. Pechoux, M. Ottmann, G. Morel, and J. L. Darlix. 1997. Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis. J. Virol. 71:6973-6981[Abstract]. |
| 5. |
Bowzard, J. B.,
R. P. Bennett,
N. K. Krishna,
S. M. Ernst,
A. Rein, and J. W. Wills.
1998.
Importance of basic residues in the nucleocapsid sequence for retrovirus Gag assembly and complementation rescue.
J. Virol.
72:9034-9044 |
| 6. | Braaten, D., E. K. Franke, and J. Luban. 1996. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 prior to the initiation of reverse transcription. J. Virol. 70:3551-3560[Abstract]. |
| 7. |
Burniston, M. T.,
A. Cimarelli,
J. Colgan,
S. P. Curtis, and J. Luban.
1999.
Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein.
J. Virol.
73:8527-8540 |
| 8. |
Campbell, S., and A. Rein.
1999.
In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain.
J. Virol.
73:2270-2279 |
| 9. | Campbell, S., and V. M. Vogt. 1995. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. J. Virol. 69:6487-6497[Abstract]. |
| 10. | Carriere, C., B. Gay, N. Chazal, N. Morin, and P. Boulanger. 1995. Sequence requirements for encapsidation of deletion mutants and chimeras of human immunodeficiency virus type 1 Gag precursor into retrovirus-like particles. J. Virol. 69:2366-2377[Abstract]. |
| 11. |
Cimarelli, A., and J. Luban.
1999.
Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein.
J. Virol.
73:5388-5401 |
| 12. |
Clavel, F., and J. M. Orenstein.
1990.
A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology.
J. Virol.
64:5230-5234 |
| 13. | Colgan, J., H. E. H. Yuan, E. K. Franke, and J. Luban. 1996. Binding of the human immunodeficiency virus type 1 Gag polyprotein to cyclophilin A is mediated by the central region of capsid and requires Gag dimerization. J. Virol. 70:4299-4310[Abstract]. |
| 14. | Darlix, J. L., M. Lapadat-Tapolsky, H. de Rocquigny, and B. P. Roques. 1995. First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. J. Mol. Biol. 254:523-537[CrossRef][Medline]. |
| 15. | Dawson, L., and X. F. Yu. 1998. The role of nucleocapsid of HIV-1 in virus assembly. Virology 251:141-157[CrossRef][Medline]. |
| 16. |
De Guzman, R. N.,
Z. R. Wu,
C. C. Stalling,
L. Pappalardo,
P. N. Borer, and M. F. Summers.
1998.
Structure of the HIV-1 nucleocapsid protein bound to the SL3 psi-RNA recognition element.
Science
279:384-388 |
| 17. |
De Rocquigny, H.,
C. Gabus,
A. Vincent,
M. C. Fournie-Zaluski,
B. Roques, and J. L. Darlix.
1992.
Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers.
Proc. Natl. Acad. Sci. USA
89:6472-6476 |
| 18. |
Dorfman, T.,
J. Luban,
S. P. Goff,
W. A. Haseltine, and H. G. Gottlinger.
1993.
Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein.
J. Virol.
67:6159-6169 |
| 19. |
Franke, E. K.,
H. E. H. Yuan,
K. L. Bossolt,
S. P. Goff, and J. Luban.
1994.
Specificity and sequence requirements for interactions between various retroviral Gag proteins.
J. Virol.
68:5300-5305 |
| 20. | Freed, E. O. 1998. HIV-1 gag proteins: diverse functions in the virus life cycle. Virology 251:1-15[CrossRef][Medline]. |
| 21. |
Fu, X.,
R. A. Katz,
A. M. Skalka, and J. Leis.
1988.
Site-directed mutagenesis of the avian retrovirus nucleocapsid protein, pp12.
J. Biol. Chem.
263:2140-2145 |
| 22. |
Gamble, T. R.,
S. Yoo,
F. F. Vajdos,
U. K. von Schwedler,
D. K. Worthylake,
H. Wang,
J. P. McCutcheon,
W. I. Sundquist, and C. P. Hill.
1997.
Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein.
Science
278:849-853 |
| 23. |
Ganser, B. K.,
S. Li,
V. Y. Klishko,
J. T. Finch, and W. I. Sundquist.
1999.
Assembly and analysis of conical models for the HIV-1 core.
Science
283:80-83 |
| 24. | Gheysen, D., E. Jacobs, F. de Foresta, C. Thiriart, M. Francotte, D. Thines, and M. DeWilde. 1989. Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell 59:103-112[CrossRef][Medline]. |
| 25. | Gross, I., H. Hohenberg, and H. G. Krausslich. 1997. In vitro assembly properties of purified bacterially expressed capsid proteins of human immunodeficiency virus. Eur. J. Biochem. 249:592-600[Medline]. |
| 26. | Huang, M., J. M. Orenstein, M. A. Martin, and E. O. Freed. 1995. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J. Virol. 69:6810-6818[Abstract]. |
| 27. |
Jowett, J. B.,
D. J. Hockley,
M. V. Nermut, and I. M. Jones.
1992.
Distinct signals in human immunodeficiency virus type 1 Pr55 necessary for RNA binding and particle formation.
J. Gen. Virol.
73:3079-3086 |
| 28. | Krausslich, H. G., and R. Welker. 1996. Intracellular transport of retroviral capsid components. Curr. Top. Microbiol. Immunol. 214:25-63[Medline]. |
| 29. |
Lapadat-Tapolsky, M.,
H. De Rocquigny,
D. Van Gent,
B. Roques,
R. Plasterk, and J. L. Darlix.
1993.
Interactions between HIV-1 nucleocapsid protein and viral DNA may have important functions in the viral life cycle.
Nucleic Acids Res.
21:831-839 |
| 30. |
Lee, Y. M.,
B. Liu, and X. F. Yu.
1999.
Formation of virus assembly intermediate complexes in the cytoplasm by wild-type and assembly-defective mutant human immunodeficiency virus type 1 and their association with membranes.
J. Virol.
73:5654-5662 |
| 31. | Lee, Y. M., and X. F. Yu. 1998. Identification and characterization of virus assembly intermediate complexes in HIV-1-infected CD4+ T cells. Virology 243:78-93[CrossRef][Medline]. |
| 32. |
Leis, J., and J. Jentoft.
1983.
Characteristics and regulation of interaction of avian retrovirus pp12 protein with viral RNA.
J. Virol.
48:361-369 |
| 33. |
Lever, A.,
H. Göttlinger,
W. Haseltine, and J. Sodroski.
1989.
Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions.
J. Virol.
63:4085-4087 |
| 34. | Luban, J., K. A. Bossolt, E. K. Franke, G. V. Kalpana, and S. P. Goff. 1993. Human immunodeficiency virus type 1 gag protein binds to cyclophilins A and B. Cell 73:1067-1078[CrossRef][Medline]. |
| 35. |
Luban, J., and S. P. Goff.
1991.
Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 gag polyprotein.
J. Virol.
65:3203-3212 |
| 36. | Mak, J., A. Khorchid, Q. Cao, Y. Huang, I. Lowy, M. A. Parniak, V. R. Prasad, M. A. Wainberg, and L. Kleiman. 1997. Effects of mutations in Pr160gag-pol upon tRNA(Lys3) and Pr160gag-pol incorporation into HIV-1. J. Mol. Biol. 265:419-431[CrossRef][Medline]. |
| 37. |
McDermott, J.,
L. Farrell,
R. Ross, and E. Barklis.
1996.
Structural analysis of human immunodeficiency virus type 1 Gag protein interactions, using cysteine-specific reagents.
J. Virol.
70:5106-5114 |
| 38. | Myers, G., B. Korber, S. Wain-Hobson, K.-T. Jeang, L. E. Henderson, and G. N. Pavlakis. 1994. Human retroviruses and AIDS. Los Alamos National Laboratory, Los Alamos, N.Mex. |
| 39. | Ottmann, M., C. Gabus, and J. L. Darlix. 1995. The central globular domain of the nucleocapsid protein of human immunodeficiency virus type 1 is critical for virion structure and infectivity. J. Virol. 69:1778-1784[Abstract]. |
| 40. |
Platt, E. J., and O. K. Haffar.
1994.
Characterization of human immunodeficiency virus type 1 Pr55gag membrane association in a cell-free system: requirement for a C-terminal domain.
Proc. Natl. Acad. Sci. USA
91:4594-4598 |
| 41. |
Poon, D. T.,
J. Wu, and A. Aldovini.
1996.
Charged amino acid residues of human immunodeficiency virus type 1 nucleocapsid p7 protein involved in RNA packaging and infectivity.
J. Virol.
70:6607-6616 |
| 42. |
Prats, A. C.,
V. Housset,
G. de Billy,
F. Cornille,
H. Prats,
B. Roques, and J. L. Darlix.
1991.
Viral RNA annealing activities of the nucleocapsid protein of Moloney murine leukemia virus are zinc independent.
Nucleic Acids Res.
19:3533-3541 |
| 43. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 44. |
Sandefur, S.,
V. Varthakavi, and P. Spearman.
1998.
The I domain is required for efficient plasma membrane binding of human immunodeficiency virus type 1 Pr55Gag.
J. Virol.
72:2723-2732 |
| 45. | Schmalzbauer, E., B. Strack, J. Dannull, S. Guehmann, and K. Moelling. 1996. Mutations of basic amino acids of NCp7 of human immunodeficiency virus type 1 affect RNA binding in vitro. J. Virol. 70:771-777[Abstract]. |
| 46. |
Schwartz, S.,
M. Campbell,
G. Nasioulas,
J. Harrison,
B. K. Felber, and G. N. Pavlakis.
1992.
Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression.
J. Virol.
66:7176-7182 |
| 47. |
Sheng, N., and S. Erickson-Viitanen.
1994.
Cleavage of p15 protein in vitro by human immunodeficiency virus type 1 protease is RNA dependent.
J. Virol.
68:6207-6214 |
| 48. | Sheng, N., S. C. Pettit, R. J. Tritch, D. H. Ozturk, M. M. Rayner, R. Swanstrom, and S. Erickson-Viitanen. 1997. Determinants of the human immunodeficiency virus type 1 p15NC-RNA interaction that affect enhanced cleavage by the viral protease. J. Virol. 71:5723-5732[Abstract]. |
| 49. |
Smith, A. J.,
N. Srinivasakumar,
M. L. Hammarskjold, and D. Rekosh.
1993.
Requirements for incorporation of Pr160gag-pol from human immunodeficiency virus type 1 into virus-like particles.
J. Virol.
67:2266-2275 |
| 50. | Swanstrom, R., and J. W. Wills. 1997. Synthesis, assembly and processing of viral proteins, p. 263-334. In J. M. Coffin, S. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 51. | Tanchou, V., C. Gabus, V. Rogemond, and J. L. Darlix. 1995. Formation of stable and functional HIV-1 nucleoprotein complexes in vitro. J. Mol. Biol. 252:563-571[CrossRef][Medline]. |
| 52. | Weiss, A., R. Wiskocil, and J. Stobo. 1984. The role of T3 surface molecules in the activation of human T cells: a two stimulus requirement for IL-2 production reflects events occurring at a pretranslational level. J. Immunol. 133:123-128[Abstract]. |
| 53. | Zhang, Y., and E. Barklis. 1997. Effects of nucleocapsid mutations on human immunodeficiency virus assembly and RNA encapsidation. J. Virol. 71:6765-6776[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»